4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-20-000021
President and CEO sold 3,374 shares at $3.86 ($13,011)
- President and CEO acquired 10,937 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Brunn Carsten · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-03-01 | Exercise or conversion : show line 1 in the form | +10,937 | 81,851 | D | ||
| 2020-03-03 | Sale : show line 2 in the form | −3,374 | $3.86 | $13,011 | 78,477 | D |
| Open-market sales · 3,374 sh · avg $3.86 · $13,011 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2020-03-01 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −10,937 | 10,937 | 120,313 | D |
Loading xslF345X03/wf-form4_158327072572666.xml…